Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 10:35 PM
Ignite Modification Date:
2025-12-25 @ 8:07 PM
NCT ID:
NCT00129935
Group ID:
EG000
Title:
Arm A: EC-T
Description:
Epirubicin with cyclophosphamide, followed by docetaxel (EC-T): Epirubicin 90 mg/ m2 in combination with cyclophosphamide 600 mg/m2 (EC) every 21 days for 4 cycles, followed by docetaxel 100 mg/m2 (T) every 21 days for 4 cycles.
Docetaxel
Epirubicin
Cyclophosphamide
Deaths Number Affected:
70
Deaths Number At Risk:
None
Serious Number Affected:
111
Serious Number At Risk:
669
Other Number Affected:
665
Other Number At Risk:
669
Study:
NCT00129935
Results Section:
NCT00129935
Adverse Events Module:
NCT00129935